Publications
39
Citations
129
Est. group size
~30
Recurring co-author estimate
Active years
9
Publishing since 2018
Typically publishes in teams of ~37 · 0% small-team papers (≤3 authors) · across 7 venues
- Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Journal of Experimental & Clinical Cancer Research · 2026
- Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma
Research Square · 2026
- Additional file 4 of Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Figshare · 2026
- Additional file 4 of Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Figshare · 2026
- Additional file 2 of Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Figshare · 2026
- Additional file 1 of Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Figshare · 2026
- Additional file 1 of Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Figshare · 2026
- Additional file 3 of Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Figshare · 2026
- Additional file 3 of Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Figshare · 2026
- Additional file 2 of Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Figshare · 2026
- Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Figshare · 2026
- Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma
Figshare · 2026
- Diffuse leptomeningeal glioneuronal tumor in an adult male without leptomeningeal enhancement: The diagnostic value of integrated molecular profiling
Journal of Neuropathology & Experimental Neurology · 2025
- Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma
Universität Zürich, ZORA · 2025
- HGG-07. Combination of CDK4/6 and MEK inhibition increases antitumor effects in pediatric high-grade glioma harboring concomitant BRAF mutation and CDKN2A/B loss
Neuro-Oncology Pediatrics · 2025
- Neuro-Oncology×13
- Figshare×10
- Neuro-Oncology Pediatrics×5
- Frontiers in Oncology×1
- Cancer Cell×1
- Madeline Miclea
Medicine · University of Michigan
- Ruby Siada
Medicine · University of Michigan
- Michael Niculcea
Medicine · University of Michigan
- Dana Messinger
Medicine · University of Michigan
- Sunjong Ji
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile